Cite
Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer.
MLA
Wen, Shu Fen, et al. “Assessment of P53 Gene Transfer and Biological Activities in a Clinical Study of Adenovirus-P53 Gene Therapy for Recurrent Ovarian Cancer.” Cancer Gene Therapy, vol. 10, no. 3, Mar. 2003, p. 224. EBSCOhost, https://doi.org/10.1038/sj.cgt.7700562.
APA
Wen, S. F., Mahavni, V., Quijano, E., Shinoda, J., Grace, M., Musco-Hobkinson, M. L., Yang, T.-Y., Chen, Y., Runnenbaum, I., Horowitz, J., Maneval, D., Hutchins, B., & Buller, R. (2003). Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer. Cancer Gene Therapy, 10(3), 224. https://doi.org/10.1038/sj.cgt.7700562
Chicago
Wen, Shu Fen, Vikas Mahavni, Erlinda Quijano, Jeremy Shinoda, Michael Grace, Mary Lynn Musco-Hobkinson, Tong-Yuan Yang, et al. 2003. “Assessment of P53 Gene Transfer and Biological Activities in a Clinical Study of Adenovirus-P53 Gene Therapy for Recurrent Ovarian Cancer.” Cancer Gene Therapy 10 (3): 224. doi:10.1038/sj.cgt.7700562.